No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Lung Cancer

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.LUNGCAN.2005.04.006PMID 15949868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.

  2004cited by this paper
• Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer.

  2004cited by this paper
• A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer

  2004cited by this paper
• Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.

  2004cited by this paper
• p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer

  2004cited by this paper
• Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.

  2004cited by this paper
• Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis

  2004cited by this paper
• MMP-9 microsatellite polymorphism and multiple sclerosis.

  2004cited by this paper
• Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.

  2004cited by this paper
• Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung.

  2003cited by this paper
• Tumour cell and stromal features in metastatic and non‐metastatic non‐small cell lung carcinomas

  2003cited by this paper
• New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression

  2003cited by this paper
• Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese.

  2003cited by this paper
• Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis.

  2003cited by this paper
• XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity.

  2003cited by this paper
• Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population

  2003cited by this paper
• Prognostic impact of matrix metalloproteinase‐9 in operable non‐small cell lung cancer

  2003cited by this paper
• Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.

  2002cited by this paper
• MMP9 potentiates pulmonary metastasis formation.

  2002cited by this paper
• A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans.

  2002cited by this paper
• Gelatinase B functions as regulator and effector in leukocyte biology

  2001cited by this paper
• A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.

  2001cited by this paper
• Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study

  2001cited by this paper
• Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.

  2001cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

  2000cited by this paper
• Matrix metalloproteinases in tumor invasion and metastasis.

  2000cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Matrix metalloproteinases in tumour invasion and metastasis

  1999cited by this paper
• Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1

  1999cited by this paper
• Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.

  1998cited by this paper
• Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.

  1997cited by this paper
• Matrix metalloproteinases

  1997cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper

• Association between variants of gelatinases and lung carcinoma risk: A systematic review, meta-analysis, trial sequential analysis with prevalence and transcriptional predictions

  2025influential citation
• Impacts of Matrix Metalloproteinase-9 Promoter Genotypes on Asthma Risk

  2024cites this paper
• Association of Matrix Metalloproteinase-9 Genotypes With Lung Cancer Risk in Taiwan

  2024cites this paper
• The multifaceted roles of matrix metalloproteinases in lung cancer

  2023cites this paper
• Impacts of Matrix Metalloproteinase 9 Genotypes on Renal Cell Carcinoma

  2023cites this paper
• The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer

  2021cites this paper
• A Single Nucleotide Polymorphism in the MMP9 Promoter Affects Lung Cancer and Clinicopathological Properties in Iranian Population

  2021cites this paper
• Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis

  2020influential citation
• Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk

  2020cites this paper
• Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk

  2019cites this paper
• ASSESSMENT OF THE RELATIONSHIP BETWEEN -1562C>T ALLELE OF MMP9 GENE PROMOTER WITH DIABETIC FOOT ULCER IN TYPE 2 DIABETIC PATIENTS REFERRED TO THE CLINIC OF DIABETES & METABOLIC DISEASES

  2018cites this paper
• Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

  2017cites this paper
• MMP2 gene-735 C/T and MMP9 gene -1562 C/T polymorphisms in JAK2V617F positive myeloproliferative disorders.

  2015cites this paper
• Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data

  2015cites this paper
• Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

  2013cites this paper
• Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.

  2013cites this paper
• Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.

  2013cites this paper
• Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis

  2012cites this paper
• Update analysis of studies on the MMP-9 −1562 C>T polymorphism and cancer risk

  2011cites this paper
• Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma.

  2011cites this paper
• Polimorfismos de la metaloproteasa de matriz 9 (MMP-9) en el diagnóstico del carcinoma prostático: Experiencia preliminar

  2010cites this paper
• Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

  2010cites this paper
• The Association of MMP-9 Enzyme Activity, MMP-9 C1562T Polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 Gene Expression in Lung Cancer

  2009influential citation
• Inflammation-associated genes and genetic variations in colorectal cancer

  2009cites this paper
• MMP2 promoter polymorphism (C‐1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation

  2008cites this paper
• Genetic Analysis of MMP Gene Polymorphisms in Patients With Kawasaki Disease

  2008cites this paper
• A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.

  2008cites this paper
• Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer

  2007cites this paper
• TSP1 and MMP9 genetic variants in sporadic prostate cancer.

  2007cites this paper
• Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.

  2007cites this paper
• Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer.

  2007cites this paper
• Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China

  2007cites this paper
• Clinical implications of matrix metalloproteinase‐1, ‐3, ‐7, ‐9, ‐12, and plasminogen activator inhibitor‐1 gene polymorphisms in colorectal cancer

  2007cites this paper
• Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression

  2007cites this paper
• Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.

  2007cites this paper
• Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population

  2006cites this paper
• Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.

  2006cites this paper
• Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.

  2006cites this paper
• Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.

  2006cites this paper